secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2024-08-26T23:59:59+00:00
Accession:  0001104659-24-092908
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel receives Nasdaq delisting notice due to equity noncompliance; trading may be suspended Sep 3
--------------------------------------------------------------------------------

- Stockholders' equity was $999K as of June 30, 2024, below Nasdaq's $2.5M minimum for continued listing.
- Nasdaq staff determined company failed to show ability to achieve or sustain compliance after prior notice in March 2024.
- Unless appeal is requested by Aug 29, 2024, trading of CYCC and CYCCP shares will be suspended at open on Sep 3, 2024.
- Management plans to request a hearing before the Nasdaq Hearings Panel, which would temporarily stay delisting.
- Previously completed an equity raise of ~$6.3M in May 2024 but still could not regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924092908/0001104659-24-092908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924092908/tm2422661d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-092908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer